Assessment Report di Comirnaty di Pfizer/BioNTech, vedi pag. 102 e segg. punto 3.3. Uncertainties and limitations about favourable effects e punto 3.5. Uncertainties and limitations about unfavourable effects
Assessment Report di Comirnaty di Pfizer/BioNTech, vedi pag. 102 e segg. punto 3.3. Uncertainties and limitations about favourable effects e punto 3.5. Uncertainties and limitations about unfavourable effects